DiNovA Israel Incubator News
4 articles
DiNovA's Israel Incubator officially opens its office in Caesarea
China-based DiNovA Medtech has opened its Israel incubator in Caesarea Industry and Business Park. The incubator aims to promote cutting-edge medtech technologies, particularly digital health innovations, by connecting Israeli medtech talents with the Chinese market. DiNovA Medtech has already established a network in Israel through collaborations, investments, and partnerships with medical experts, engineers, and venture capitalists. The incubator plans to launch 2 to 3 medtech innovations or digital medical projects annually. The office is located in close proximity to other high-tech and medtech companies. The companys CEO expressed the importance of global collaboration for DiNovAs business model, while the CMO highlighted the opportunities for collaboration and the establishment of the office despite the challenges posed by the pandemic.
PartnersInvestment
EndoWays LTD, Developer of the First Disposable Robot for the Cathlab, Acquired by Ascendum
EndoWays, a developer of a disposable robotic system for the cathlab, has announced the completion of an acquisition of a majority of its shares by Ascendum. The acquisition amount was undisclosed. The deal will provide EndoWays with access to the experience and network of the Ascendum team, helping accelerate its clinical and commercial development, especially in China. EndoWays was founded in 2018 and is a portfolio company of MEDX Xelerator. The company has developed a fully disposable robotic system for navigation and operation within blood vessels in neurovascular, peripheral, and cardiac procedures. The acquisition is seen as a significant milestone for EndoWays, and the company will continue its development until commercial launch.
Acquisition
Chaim Lotan, MD announces the official launch of DiNovA's Israel Incubator at ICI
DiNovA Medtech has officially launched the DiNovA Israel Incubator, aimed at promoting cutting-edge medtech technologies, particularly in digital health. The incubator will bridge Israeli medtech engineering talent with the Chinese market, bringing together resources from both countries to create medical technology innovations. DiNovA Medtechs portfolio companies have previously made investments in Israeli companies such as Keystone Heart, NoYA Medical, Human Xtentions, Healium Medical, and Pi-Cardia. The new incubator plans to invest in three or more projects in Israel annually. Additionally, four existing portfolio companies of DiNovA Medtech based in mainland China introduced their advanced technologies and latest clinical developments. The companies are actively seeking clinical collaborators in the EU for upcoming multi-center clinical trials in 2021.
PartnersInvestmentExpand
DiNovA Medtech Announces Chaim Lotan, MD to Join as DiNovA Israel Incubator's Co-founder and Chief Medical Officer
DiNovA Medtech announces the appointment of Chaim Lotan as Co-founder and Chief Medical Officer of DiNovA Israel Incubator. The incubator aims to promote cutting-edge medtech technologies, particularly digital health innovations, by connecting resources in Israel and China. Prof. Lotan, a renowned cardiologist and innovator, has been collaborating with DiNovA for many years and is also involved in other portfolio companies. The establishment of the incubator in Israel is seen as a step towards fostering collaboration between the two countries in medical technology innovation. DiNovA Medtech is a specialized medical device incubator that operates globally.
Partners
